Literature DB >> 29263224

Progranulin: Functions and neurologic correlations.

Ryan A Townley1, Bradley F Boeve1, Eduardo E Benarroch2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29263224      PMCID: PMC5772162          DOI: 10.1212/WNL.0000000000004840

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  87 in total

1.  Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations.

Authors:  Keith A Josephs; Zeshan Ahmed; Omi Katsuse; Joseph F Parisi; Bradley F Boeve; David S Knopman; Ronald C Petersen; Peter Davies; Ranjan Duara; Neill R Graff-Radford; Ryan J Uitti; Rosa Rademakers; Jennifer Adamson; Matthew Baker; Michael L Hutton; Dennis W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  2007-02       Impact factor: 3.685

2.  The Progranulin Cleavage Products, Granulins, Exacerbate TDP-43 Toxicity and Increase TDP-43 Levels.

Authors:  Dominique A Salazar; Victoria J Butler; Andrea R Argouarch; Tsung-Yuan Hsu; Amanda Mason; Ayumi Nakamura; Helen McCurdy; David Cox; Rachel Ng; Gloria Pan; William W Seeley; Bruce L Miller; Aimee W Kao
Journal:  J Neurosci       Date:  2015-06-24       Impact factor: 6.167

3.  Multiple therapeutic effects of progranulin on experimental acute ischaemic stroke.

Authors:  Masato Kanazawa; Kunio Kawamura; Tetsuya Takahashi; Minami Miura; Yoshinori Tanaka; Misaki Koyama; Masafumi Toriyabe; Hironaka Igarashi; Tsutomu Nakada; Masugi Nishihara; Masatoyo Nishizawa; Takayoshi Shimohata
Journal:  Brain       Date:  2015-04-02       Impact factor: 13.501

4.  A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology.

Authors:  J B Leverenz; C E Yu; T J Montine; E Steinbart; L M Bekris; C Zabetian; L K Kwong; V M-Y Lee; G D Schellenberg; T D Bird
Journal:  Brain       Date:  2007-04-17       Impact factor: 13.501

5.  Corticobasal syndrome associated with the A9D Progranulin mutation.

Authors:  Salvatore Spina; Jill R Murrell; Edward D Huey; Eric M Wassermann; Pietro Pietrini; Jordan Grafman; Bernardino Ghetti
Journal:  J Neuropathol Exp Neurol       Date:  2007-10       Impact factor: 3.685

Review 6.  What we know about TMEM106B in neurodegeneration.

Authors:  Alexandra M Nicholson; Rosa Rademakers
Journal:  Acta Neuropathol       Date:  2016-08-20       Impact factor: 17.088

Review 7.  Mechanisms of granulin deficiency: lessons from cellular and animal models.

Authors:  Gernot Kleinberger; Anja Capell; Christian Haass; Christine Van Broeckhoven
Journal:  Mol Neurobiol       Date:  2012-12-13       Impact factor: 5.590

8.  Progranulin, a glycoprotein deficient in frontotemporal dementia, is a novel substrate of several protein disulfide isomerase family proteins.

Authors:  Sandra Almeida; Lijuan Zhou; Fen-Biao Gao
Journal:  PLoS One       Date:  2011-10-18       Impact factor: 3.240

9.  Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics.

Authors:  Jennifer L Whitwell; Stephen D Weigand; Bradley F Boeve; Matthew L Senjem; Jeffrey L Gunter; Mariely DeJesus-Hernandez; Nicola J Rutherford; Matthew Baker; David S Knopman; Zbigniew K Wszolek; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Rosa Rademakers; Clifford R Jack; Keith A Josephs
Journal:  Brain       Date:  2012-03       Impact factor: 13.501

10.  White matter lesions in FTLD: distinct phenotypes characterize GRN and C9ORF72 mutations.

Authors:  Fatima Ameur; Olivier Colliot; Paola Caroppo; Sebastian Ströer; Didier Dormont; Alexis Brice; Carole Azuar; Bruno Dubois; Isabelle Le Ber; Anne Bertrand
Journal:  Neurol Genet       Date:  2016-01-28
View more
  4 in total

Review 1.  Experimental Disease-Modifying Agents for Frontotemporal Lobar Degeneration.

Authors:  Marcello Giunta; Eino Solje; Fabrizio Gardoni; Barbara Borroni; Alberto Benussi
Journal:  J Exp Pharmacol       Date:  2021-03-24

Review 2.  Advances in the development of new biomarkers for Alzheimer's disease.

Authors:  Timofey O Klyucherev; Pawel Olszewski; Alena A Shalimova; Vladimir N Chubarev; Vadim V Tarasov; Misty M Attwood; Stina Syvänen; Helgi B Schiöth
Journal:  Transl Neurodegener       Date:  2022-04-21       Impact factor: 9.883

3.  Decreased Prosaposin and Progranulin in the Cingulate Cortex Are Associated with Schizophrenia Pathophysiology.

Authors:  Yachao He; Xiaoqun Zhang; Ivana Flais; Per Svenningsson
Journal:  Int J Mol Sci       Date:  2022-10-10       Impact factor: 6.208

Review 4.  Microglia and astrocyte involvement in neurodegeneration and brain cancer.

Authors:  Arthur A Vandenbark; Halina Offner; Szymon Matejuk; Agata Matejuk
Journal:  J Neuroinflammation       Date:  2021-12-23       Impact factor: 8.322

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.